Clik here to view.
思摩尔启动有关尼古丁成瘾的开创性研究项目
中国深圳 (美国商业资讯)–全球领先的电子烟产品制造商思摩尔(SMOORE)今天宣布，公司已启动世界上首个尼古丁成瘾实时监测研究项目。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20220705005432/zh-CN/ （照片：美国商业资讯）...
View ArticleClik here to view.
スモアがニコチン中毒の先駆的な研究プロジェクトを発足
中国・深セン （ビジネスワイヤ） — 世界最大の電子たばこメーカーであるスモアは本日、ニコチン中毒に関する世界初のリアルタイムモニタリング研究プロジェクトを発足させたと発表しました。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：https://www.businesswire.com/news/home/20220705005434/ja/...
View ArticleClik here to view.
Aurigene Discovery Technologies Limited宣布与EQRx建立药物发现、开发和商业化合作伙伴关系
印度班加罗尔 (美国商业资讯)–双方的合作将Aurigene的小分子药物发现平台和EQRx的开创性商业模式进行整合，从而加快肿瘤和免疫炎症疾病领域候选药物的开发，改善全球创新药物的获取途径。...
View ArticleClik here to view.
CHA Health Systems Partners With Ceras Health to Improve Real-Time Care...
LOS ANGELES CHA Health Systems (CHS), a global leader in healthcare and biotechnology, today announced a partnership with digital healthcare services company Ceras Health (Ceras) to use its...
View ArticleClik here to view.
CANbridge Forms Scientific Advisory Board to Guide Global Development of...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc. (HKEX:1228), a China and US-based global biopharmaceutical company committed to the research, development and commercialization of...
View ArticleClik here to view.
Clik here to view.
KBI Biopharma和Selexis在瑞士日内瓦举行先进设施扩建的联合剪彩仪式
日内瓦 (美国商业资讯)–JSR Life Sciences旗下公司KBI Biopharma SA (KBI)和Selexis SA昨天在瑞士日内瓦新落成的先进设施举行了联合剪彩仪式。该设施旨在直接服务于欧洲日益增长的生物制药药物开发和生产需求，将支持Selexis的细胞系开发(CLD)服务和KBI的合同开发和制造服务的一体化端到端流程，为邻近地区和其他地区的行业客户提供服务。...
View ArticleClik here to view.
ウロリチンA（マイトピュア）がミトコンドリアの健康を改善し、関節軟骨の損傷を軽減し、変形性関節症の痛みを緩和することを示す新たな研究
スイス・ローザンヌ & サンフランシスコ （ビジネスワイヤ） —...
View ArticleClik here to view.
新研究显示尿石素A (Mitopure®)可改善线粒体健康，减少关节软骨损伤并减轻骨关节炎疼痛
瑞士洛桑和旧金山 (美国商业资讯)–Amazentis是瑞士联邦理工学院(EPFL)的衍生公司，引领细胞健康和营养领域的科学突破。公司今天宣布，同行评议期刊《细胞衰老》(Aging Cell)新刊发的临床前结果显示，肠道微生物组后生元尿石素A (UA)有益于关节健康。这是在骨关节炎(OA)实验室模型中首次显示某一化合物可改善线粒体健康。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
玫琳凯公司与Jack Gilbert博士合作，深入研究皮肤“微生物组”及其对衰老过程的影响
达拉斯 (美国商业资讯)–全球领先的护肤研究公司玫琳凯公司(Mary Kay Inc.)宣布，公司已与加州大学圣地亚哥分校医学院儿科教授、加州大学圣地亚哥分校斯克里普斯海洋研究所微生物海洋学教授Jack Gilbert博士建立新的合作伙伴关系。通过合作，玫琳凯的科学家将与Gilbert博士联手，研究对衰老和皮肤健康极为重要但人们却所知甚少的领域：皮肤微生物组。...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Fesoterodine Fumarate...
HYDERABAD, India &PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”)...
View ArticleClik here to view.
Clik here to view.
Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTA®...
BOSTON & SHANGHAI & LAUSANNE, Switzerland Overland ADCT BioPharma, a joint venture created by Overland Pharmaceuticals (“Overland”) and ADC Therapeutics SA (NYSE: ADCT), today announced the...
View ArticleClik here to view.
PHC株式会社：PHCbi、独自の電気化学式センサー技術を活用した研究用「ライブセル代謝分析装置」のプロトタイプを開発～細胞治療の産業化に向けた課題解決へ...
東京 （ビジネスワイヤ） — ライフサイエンス分野において研究・医療支援機器およびサービスをグローバルに提供するPHC株式会社 バイオメディカ事業部（以下、「PHCbi」）は、7月13日（水）から7月15日（金）まで東京ビッグサイトで開催される「第4回ファーマラボEXPO東京」（主催：RX...
View ArticleClik here to view.
Extension of the postponement of the settlement of Vifor Pharma tender offer
MELBOURNE, Australia & ST. GALLEN, Switzerland Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220712006199/en/ AD...
View ArticleClik here to view.
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for...
GUANGZHOU, China Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8006, an antibody...
View ArticleClik here to view.
Telstra Appoints Steve Mundt to Head Enterprise and Technology Sales for the...
NEW YORK Telstra has named Steve Mundt as Vice President of Enterprise and Technology for the Americas, responsible for direct sales and new business development across the region. This press...
View ArticleClik here to view.
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In...
BEIJING Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its COVID-19 vaccine (CoronaVac) has been approved...
View ArticleClik here to view.
Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for...
LITTLETON, Colo. Vivos Therapeutics, Inc. (NASDAQ: VVOS) is pleased to announce that it has received multiple Class I clearances by the Therapeutic Goods Administration for multiple indications to...
View ArticleClik here to view.
First Patient Dosed in CAN108 (Maralixibat) EMBARK Phase 2 Study in Biliary...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading China and US-based global biopharmaceutical company committed to the research, development and commercialization...
View Article